See May's 10 most read stories, including COVID-19's related nutrition stories, as well as regional industry developments in Australia and China.
Thailand and Laos are following China’s footstep in embracing a TCM formula in light of the COVID-19 pandemic.
Australian-listed Jatenergy has revealed record-breaking sales as demand for its lactoferrin dairy products surged in China.
Industry leaders in Australia have hailed cross-party agreement that will lead to five years protection for clinical trials for complementary medicines and supplements, a world-first move that trade body Complementary Medicines Australia (CMA) says will reward companies at the cutting edge of research.
Health authorities should reassess the Recommended Daily Allowance (RDA) of key micronutrients such as vitamin C and D to support the immune system, said a group of researchers.
Australian regulator, the Therapeutic Goods Administration (TGA) is reviewing recent reported cases of vitamin B6 intake and the possible side effect of peripheral neuropathy.
Nestle is conducting consumer testing with a view to expanding its customisable 'superfood' drink product, nesQino, to more APAC markets, after an initial launch in China via e-commerce platform Tmall.
As the two countries engage in an increasingly hostile war of words over the COVID-19 outbreak, could the Australian supplement industry’s huge export success to China now be under threat? Editor-in-Chief Gary Scattergood assesses the risk of collateral damage.
Cenovis, a vitamin brand under Sanofi Consumer Healthcare, has revealed vitamins B, C, and E as its bestsellers in China.
Australian-based Homart Pharmaceuticals is launching three vitamin C products under the Toplife and Springleaf brands to tap on rising demand for immune-related products during the COVID-19 pandemic.
China is stepping up its compliance checks on food manufacturers and retailers to stem the unauthorised production and sales of special foods, including Foods for Special Medical Purpose (FSMPs).
